JP2023519304A5 - - Google Patents
Info
- Publication number
- JP2023519304A5 JP2023519304A5 JP2022558042A JP2022558042A JP2023519304A5 JP 2023519304 A5 JP2023519304 A5 JP 2023519304A5 JP 2022558042 A JP2022558042 A JP 2022558042A JP 2022558042 A JP2022558042 A JP 2022558042A JP 2023519304 A5 JP2023519304 A5 JP 2023519304A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antigen
- cell
- antibody
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063000694P | 2020-03-27 | 2020-03-27 | |
| US63/000,694 | 2020-03-27 | ||
| PCT/US2021/024431 WO2021195536A1 (en) | 2020-03-27 | 2021-03-26 | Immunotherapeutic targets in multiple myeloma and methods for their identification |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023519304A JP2023519304A (ja) | 2023-05-10 |
| JP2023519304A5 true JP2023519304A5 (enExample) | 2024-02-27 |
Family
ID=77890610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022558042A Pending JP2023519304A (ja) | 2020-03-27 | 2021-03-26 | 多発性骨髄腫における免疫療法の標的およびその同定方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230137672A1 (enExample) |
| EP (1) | EP4126243A4 (enExample) |
| JP (1) | JP2023519304A (enExample) |
| KR (1) | KR20220160053A (enExample) |
| CN (1) | CN116097096A (enExample) |
| CA (1) | CA3175860A1 (enExample) |
| IL (1) | IL296714A (enExample) |
| WO (1) | WO2021195536A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12122839B2 (en) | 2020-08-05 | 2024-10-22 | Synthekine, Inc. | IFNGR binding synthetic cytokines and methods of use |
| WO2022031890A1 (en) | 2020-08-05 | 2022-02-10 | Synthekine, Inc. | Ifngr2 binding molecules and methods of use |
| US20230365696A1 (en) * | 2020-08-05 | 2023-11-16 | Synthekine, Inc. | Ifngr1 binding molecules and methods of use |
| CN114031690B (zh) * | 2021-12-03 | 2022-07-15 | 广州百暨基因科技有限公司 | 靶向ccr1和nkg2d配体的嵌合抗原受体及其应用 |
| GB202117928D0 (en) | 2021-12-11 | 2022-01-26 | Cancer Research Tech Ltd | Immunotherapy for cancer |
| CN116712550A (zh) * | 2023-07-11 | 2023-09-08 | 中国医学科学院血液病医院(中国医学科学院血液学研究所) | 治疗高增殖活性和多药耐药的多发性骨髓瘤的组合物及其应用 |
| CN118501473A (zh) * | 2024-05-22 | 2024-08-16 | 中国人民解放军海军军医大学第二附属医院 | 一种IgD型多发性骨髓瘤筛查试剂盒及其筛查系统 |
| CN118878662A (zh) * | 2024-09-03 | 2024-11-01 | 北京大学第六医院 | 多肽及其应用、试剂盒及其应用 |
| CN120943960B (zh) * | 2025-08-04 | 2026-05-08 | 郑州大学第一附属医院 | 靶向人cd180的特异性单克隆抗体及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6046012A (en) * | 1993-07-19 | 2000-04-04 | Hoffmann-La Roche Inc. | Antibody to IL-12 receptor |
| US20030092002A1 (en) * | 1997-09-17 | 2003-05-15 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| ES2586850T3 (es) * | 1999-11-29 | 2016-10-19 | The Trustees Of Columbia University In The City Of New York | Aislamiento de cinco genes novedosos que codifican nuevos melanomas de tipo receptor de Fc implicados en la patogénesis del linfoma/melanoma |
| US8679771B2 (en) * | 2007-01-25 | 2014-03-25 | The Regents Of The University Of California | Specific N-terminal labeling of peptides and proteins in complex mixtures |
| WO2012022634A1 (en) * | 2010-08-16 | 2012-02-23 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Classification, diagnosis and prognosis of multiple myeloma |
| GB2495113A (en) * | 2011-09-29 | 2013-04-03 | Bioinvent Int Ab | Anti-ICAM-1 antibody for treating multiple-myeloma-related disorders |
| CA2892490A1 (en) * | 2012-11-26 | 2014-05-30 | Caris Science, Inc. | Biomarker compositions and methods |
| DK3105317T3 (en) * | 2014-02-14 | 2019-01-14 | Cellectis | Immunotherapy cells that are genetically engineered to target antigen on both immune cells and pathological cells |
| GB201511191D0 (en) * | 2015-06-25 | 2015-08-12 | Immatics Biotechnologies Gmbh | T-cell epitopes for the immunotherapy of myeloma |
| CA2992797A1 (en) * | 2015-08-03 | 2017-02-09 | Engmab Sarl | Monoclonal antibodies against bcma |
| US10746739B2 (en) * | 2015-09-14 | 2020-08-18 | Leukemia Therapeutics, LLC | Identification of novel diagnostics and therapeutics by modulating RhoH |
| US20170234874A1 (en) * | 2015-10-07 | 2017-08-17 | Clearbridge Biophotonics Pte Ltd. | Integrated visual morphology and cell protein expression using resonance-light scattering |
| FR3051555B1 (fr) * | 2016-05-20 | 2018-05-11 | Horiba Abx Sas | Detection de la maladie residuelle du myelome multiple |
| EP3344263A4 (en) * | 2016-08-04 | 2020-07-01 | Memorial Sloan-Kettering Cancer Center | CANCER ANTIGEN TARGETS AND USES THEREOF |
| MX2019003462A (es) * | 2016-09-28 | 2019-08-16 | Gavish Galilee Bio Appl Ltd | Una plataforma universal para el tratamiento con car que se dirige a una novedosa firma antigenica del cancer. |
| US20190365806A1 (en) * | 2016-11-02 | 2019-12-05 | Universität Basel | Immunologically discernible cell surface variants for use in cell therapy |
| WO2019094360A1 (en) * | 2017-11-07 | 2019-05-16 | The Board Of Regents Of The University Of Texas System | Targeting lilrb4 with car-t or car-nk cells in the treatment of cancer |
| AU2018368431B2 (en) * | 2017-11-14 | 2024-03-21 | Arcellx, Inc. | Multifunctional immune cell therapies |
| CA3082611A1 (en) * | 2017-11-17 | 2019-05-23 | Memorial Sloan-Kettering Cancer Center | Methods and compositions for alleviating cytokine release syndrome |
| EP4219559A3 (en) * | 2017-12-22 | 2023-10-18 | Jounce Therapeutics, Inc. | Antibodies for lilrb2 |
| WO2020033585A1 (en) * | 2018-08-07 | 2020-02-13 | The Broad Institute, Inc. | Methods for combinatorial screening and use of therapeutic targets thereof |
-
2021
- 2021-03-26 EP EP21775630.3A patent/EP4126243A4/en active Pending
- 2021-03-26 JP JP2022558042A patent/JP2023519304A/ja active Pending
- 2021-03-26 CN CN202180024834.4A patent/CN116097096A/zh active Pending
- 2021-03-26 US US17/913,189 patent/US20230137672A1/en active Pending
- 2021-03-26 WO PCT/US2021/024431 patent/WO2021195536A1/en not_active Ceased
- 2021-03-26 KR KR1020227037268A patent/KR20220160053A/ko active Pending
- 2021-03-26 IL IL296714A patent/IL296714A/en unknown
- 2021-03-26 CA CA3175860A patent/CA3175860A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7749055B2 (ja) | 抗体送達のための組成物及び方法 | |
| CN112469829B (zh) | 包含抗gpc3单链抗体的car | |
| RU2761980C2 (ru) | Композиции и способы лечения аутоиммунных заболеваний и рака | |
| TW202206453A (zh) | 表現嵌合抗原受體之病毒特異性免疫細胞 | |
| KR102316091B1 (ko) | Bcma를 표적으로 하는 키메라 항원 수용체 및 이의 용도 | |
| JP2018504094A (ja) | Ｆｃ受容体様５を標的とするキメラ抗原受容体およびその使用 | |
| JP2018513687A5 (enExample) | ||
| EP3420090A1 (en) | Transposon system and methods of use | |
| KR20190111058A (ko) | TGF-β 디코이 수용체 | |
| KR20220018479A (ko) | 동종이계 car-t 세포, 이의 제조 및 응용 | |
| JP2022554395A (ja) | がんを処置するためのスプライシング由来抗原の同定 | |
| CN116097096A (zh) | 多发性骨髓瘤中的免疫治疗靶点及其鉴定方法 | |
| WO2020018691A1 (en) | Modified t cells and methods of their use | |
| CN116583294A (zh) | 抗炎细胞因子及其使用方法 | |
| KR20220108045A (ko) | 공유 후보 항원 및 공유 항원-특이적 t 림프구 쌍을 확인 및 검증하기 위한 방법 및 시스템 | |
| CN115819592A (zh) | 靶向ror1的抗原结合蛋白 | |
| KR20240004680A (ko) | 키메라 수용체 및 이의 사용 방법 | |
| JP4579836B2 (ja) | 上皮細胞増殖因子受容体（ｅｇｆｒ）由来ペプチド | |
| WO2022232797A2 (en) | Virus-specific immune cells expressing chimeric antigen receptors | |
| KR20230124912A (ko) | 키메라 수용체 및 이의 사용 방법 | |
| AU2021396878A1 (en) | Car t cells for treating cd19+, cd20+ or cd22+ tumors or b-cell derived auto-immune diseases | |
| JP2023179549A (ja) | 腫瘍抗原をコードする麻疹ウイルス | |
| IL296755A (en) | Monoclonal antibodies targeting hsp70 and their therapeutic uses | |
| CN115894691A (zh) | 靶向ror1的抗原结合蛋白 | |
| EP4704864A2 (en) | Anaplastic lymphoma kinase (alk) specific t cell receptors and methods of use thereof |